Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
5(100.0%)
5Total
N/A(5)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT01646788Not ApplicableUnknown

Study of NMB Drug Ejecting Balloon for Arteriovenous Fistulae

Role: lead

NCT01646801Not ApplicableUnknown

Study of NMB Drug Ejecting Balloon for Peripheral Arteries

Role: lead

NCT01538108Not ApplicableUnknown

Study of NMB (Company's Name) Drug Ejecting Balloon for Arteriovenous Fistulae

Role: lead

NCT01087463Not ApplicableUnknown

Intramedullary Fixation of Humerus Fractures Without Intramedullary Reaming

Role: lead

NCT01017289Not ApplicableUnknown

Intramedullary Fixation of Humerus Fractures

Role: lead

All 5 trials loaded